 | | NETWORK: N00364 | |
| Entry |
|
| Name |
HPV E5 to antigen processing and presentation by MHC class I molecules
|
| Definition |
E5 -| (MHCI+BCAP31) |
| Expanded |
K21812 -| ((3105,3106,3107,3133,3134,3135)+10134) |
| Class |
|
| Type |
Pathogen
|
| Pathway |
|
| Disease |
|
| Gene |
| 3105 | HLA-A; major histocompatibility complex, class I, A |
| 3106 | HLA-B; major histocompatibility complex, class I, B |
| 3107 | HLA-C; major histocompatibility complex, class I, C |
| 3133 | HLA-E; major histocompatibility complex, class I, E |
| 3134 | HLA-F; major histocompatibility complex, class I, F |
| 3135 | HLA-G; major histocompatibility complex, class I, G |
| 10134 | BCAP31; B cell receptor associated protein 31 |
|
| Perturbant |
| K21812 (E5) | E5; HPV protein E5 |
|
| Reference |
|
| Authors |
Moody CA, Laimins LA |
| Title |
Human papillomavirus oncoproteins: pathways to transformation. |
| Journal |
|
| Reference |
|
| Authors |
Sandberg A, Lindell G, Kallstrom BN, Branca RM, Danielsson KG, Dahlberg M, Larson B, Forshed J, Lehtio J |
| Title |
Tumor proteomics by multivariate analysis on individual pathway data for characterization of vulvar cancer phenotypes. |
| Journal |
|
| Reference |
|
| Authors |
Tummers B, Burg SH |
| Title |
High-risk human papillomavirus targets crossroads in immune signaling. |
| Journal |
|
| LinkDB |
|
|
|